AI accelerates the hunt for cures—from superbugs to Parkinson's.

AI is speeding up drug discovery by screening millions of compounds to find new antibiotics against drug-resistant bacteria such as Neisseria gonorrhoeae and MRSA, and by identifying potential Parkinson's therapies through machine learning. The technology is also repurposing existing drugs for rare diseases and creating virtual disease models to test treatments, potentially slashing development time and costs—though validation, data access, and the long path to clinical use remain significant hurdles.